Paris forrestii
Paris forrestii · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Paris forrestii is a botanical species characterized by its unique chemical profile and medicinal potential. The plant's bioactive properties are primarily derived from its rhizome, which serves as the central source for pharmacological study. Researchers often utilize an 80% EtOH extract or the processed Rhizoma Paridis to isolate its potent constituents. Key secondary metabolites found within the plant include Dichotomin, Gracillin, Kingianoside K, and Polyphyllin V. These specific compounds highlight the complex phytochemical landscape that makes this species a subject of significant interest.
- Synonyms
- Daiswa Forrestii · Paris Longistigmata · 3 more
- Common names
- Not available
- Family
- Melanthiaceae
- Distribution
- Not available
- Plant Parts
- Rhizome
Classification
Common Names
Paris forrestii is a distinctive botanical species known by its common Chinese name, changzhu zhonglou. This plant holds a unique place in regional flora, often recognized by local enthusiasts and researchers alike. Its traditional nomenclature reflects a deep cultural connection to the specific characteristics of the species. Understanding these linguistic relationships provides valuable insight into how the plant is categorized within its native habitat. Consequently, mastering both its scientific and common names is essential for anyone studying its ecological significance.
Sources: Catalogue of Life (COL)
Synonyms
Paris forrestii is a complex species that has been identified under several different botanical names throughout its taxonomic history. Scientific records indicate that it is synonymous with Daiswa forrestii, reflecting historical shifts in classification. Furthermore, the plant has been previously cataloged as Paris dulongensis and Paris longistigmata in various studies. Researchers have also linked it to the names Paris rugosa and Paris tengchongensis depending on the regional context. Understanding these various synonyms is essential for maintaining accuracy in botanical research and plant identification.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Paris forrestii is a unique botanical specimen belonging to the kingdom Plantae. Within this vast realm, the plant is classified under the class Equisetopsida. It further descends through the order Liliales, showcasing its specific evolutionary lineage. As a member of the genus Paris, it maintains a distinct identity among its relatives. Finally, its biological placement is solidified within the family Melanthiaceae.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Liliales |
| Family | Melanthiaceae |
| Genus | Paris |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Paris forrestii exhibits a diverse geographical range that spans both temperate and tropical regions of Asia. In the temperate zones, this species is found throughout various parts of China, including the South-Central regions and the high altitudes of Tibet. Its presence extends into the tropical landscapes of the Indian Subcontinent, specifically within Assam and Nepal. Additionally, the plant can be located within the tropical environments of Indo-China, notably in Myanmar. This broad distribution highlights the plant's ability to adapt to varied ecological niches across the continent.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Paris forrestii is a self-supporting plant that maintains its own structure without the need for external climbing or support.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Paris forrestii is a significant medicinal plant distinguished by its high concentration of bioactive steroidal saponins. Research indicates that this species contains polyphyllin V and gracillin as its primary saponin components. Furthermore, the chemical profile of the plant includes key compounds such as dichotomin and kingianoside K. It also contains parisyunnanoside D, which has demonstrated notable cytotoxicity against various human cancer cell lines. Together, these chemical constituents highlight the complex phytochemical importance of the species.
Conditions
Paris forrestii exhibits significant therapeutic potential by treating various cancer cell lines, including A549 lung cancer. The plant also demonstrates efficacy in treating MCF-7 breast cancer cells. Furthermore, it serves as a treatment for SMMC-7721 liver cancer. Its medicinal properties extend to the treatment of SW480 colon solid cancer cell lines. Finally, the plant is utilized for its anti-AChE activities.
Preparations
Paris forrestii is prepared as an 80% EtOH extract to facilitate the investigation of its chemical constituents. This specific extraction method is utilized to isolate important compounds from the plant's rhizomes. Additionally, Paris forrestii is prepared as Rhizoma Paridis for potential medicinal use. These preparation methods are essential for studying the plant's steroidal glycosides and bioactive properties. Consequently, both the extract and the Rhizoma Paridis form serve as primary subjects for phytochemical research.
Parts used
Paris forrestii shares botanical characteristics with other members of the genus, including the presence of a specialized rhizome. This specific plant part serves as a vital source of complex chemical constituents within the genus. Research into related species like Paris tengchongensis has demonstrated that the rhizome contains significant quantities of steroidal glycosides. Such findings highlight the medicinal potential inherent in the rhizomes of these forest-dwelling plants. Ultimately, understanding these morphological relationships provides essential insight into the phytochemical value of the Paris genus.